Brian Thomas
Founder at METAGENOMI, INC.
Net worth: 17 M $ as of 2024-04-29
Profile
Brian C.
Thomas is the founder of Metagenomi Technologies LLC and Metagenomi, Inc. which were both founded in 2016.
He held the title of Chief Executive Officer & Director at both companies.
Currently, he is the Chairman at HAYA Therapeutics SA since 2022.
Previously, he worked as a Program Manager at Berkeley University of California.
Dr. Thomas received his undergraduate and doctorate degrees from the University of Kansas.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
METAGENOMI, INC.
6.66% | 2024-03-31 | 2,496,276 ( 6.66% ) | 17 M $ | 2024-04-29 |
Brian Thomas active positions
| Companies | Position | Start |
|---|---|---|
| METAGENOMI, INC. | Founder | 2016-09-15 |
HAYA Therapeutics SA
 HAYA Therapeutics SA BiotechnologyHealth Technology HAYA Therapeutics SA is a Swiss precision medicines company that focuses on developing programmable therapeutics targeting regulatory RNAs derived from the dark genome to reprogram pathological cell states for a broad range of diseases, including cardiovascular disease and cancer. The company's discovery engine identifies novel targets and drug candidates with the potential for greater efficacy and safety than existing treatments. HAYA's lead therapeutic candidate is HTX-001, an antisense oligonucleotide targeting WISPER that is a heart-specific lncRNA known to be a fundamental regulator of pathological cardiac fibrosis in the context of heart failure. The company is headquartered at the Life Sciences Park Biopôle in Lausanne, CH, with laboratory facilities at JLABS @ San Diego. The company was founded by Samir Ounzain and Daniel Blessing, and Samir Ounzain has been the CEO since incorporation. | Chairman | 2022-09-13 |
Former positions of Brian Thomas
| Companies | Position | End |
|---|---|---|
| Berkeley University of California | Corporate Officer/Principal | - |
Metagenomi Technologies LLC
 Metagenomi Technologies LLC BiotechnologyHealth Technology Metagenomi Technologies LLC engages in the development of curative therapeutics and gene-editing technologies and therapies. The company was founded by Brian C. Thomas in September 2016 and is headquartered in Emeryville, CA. | Founder | - |
Training of Brian Thomas
| University of Kansas | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| METAGENOMI, INC. | Health Technology |
| Private companies | 2 |
|---|---|
HAYA Therapeutics SA
HAYA Therapeutics SA BiotechnologyHealth Technology HAYA Therapeutics SA is a Swiss precision medicines company that focuses on developing programmable therapeutics targeting regulatory RNAs derived from the dark genome to reprogram pathological cell states for a broad range of diseases, including cardiovascular disease and cancer. The company's discovery engine identifies novel targets and drug candidates with the potential for greater efficacy and safety than existing treatments. HAYA's lead therapeutic candidate is HTX-001, an antisense oligonucleotide targeting WISPER that is a heart-specific lncRNA known to be a fundamental regulator of pathological cardiac fibrosis in the context of heart failure. The company is headquartered at the Life Sciences Park Biopôle in Lausanne, CH, with laboratory facilities at JLABS @ San Diego. The company was founded by Samir Ounzain and Daniel Blessing, and Samir Ounzain has been the CEO since incorporation. | Health Technology |
Metagenomi Technologies LLC
Metagenomi Technologies LLC BiotechnologyHealth Technology Metagenomi Technologies LLC engages in the development of curative therapeutics and gene-editing technologies and therapies. The company was founded by Brian C. Thomas in September 2016 and is headquartered in Emeryville, CA. | Health Technology |
- Stock Market
- Insiders
- Brian Thomas
